Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innospec (IOSP) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Innospec (IOSP) over the last 17 years, with Q3 2025 value amounting to $496.5 million.

  • Innospec's Total Liabilities fell 974.37% to $496.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $496.5 million, marking a year-over-year decrease of 974.37%. This contributed to the annual value of $518.6 million for FY2024, which is 702.76% down from last year.
  • Latest data reveals that Innospec reported Total Liabilities of $496.5 million as of Q3 2025, which was down 974.37% from $504.6 million recorded in Q2 2025.
  • Innospec's Total Liabilities' 5-year high stood at $577.3 million during Q3 2022, with a 5-year trough of $467.0 million in Q1 2021.
  • Its 5-year average for Total Liabilities is $526.0 million, with a median of $518.6 million in 2024.
  • Per our database at Business Quant, Innospec's Total Liabilities surged by 1953.56% in 2021 and then tumbled by 1503.55% in 2023.
  • Innospec's Total Liabilities (Quarter) stood at $537.9 million in 2021, then increased by 4.72% to $563.3 million in 2022, then dropped by 0.98% to $557.8 million in 2023, then decreased by 7.03% to $518.6 million in 2024, then fell by 4.26% to $496.5 million in 2025.
  • Its Total Liabilities stands at $496.5 million for Q3 2025, versus $504.6 million for Q2 2025 and $508.9 million for Q1 2025.